RAC1 and colonic neoplasm: To test whether the observed decrease in Cdc42 and Rac1 and increase in ROCK activity were both involved in tumour progression to more advanced stages, we treated these three colon cancer cell lines with PDGF to re-activate Cdc42 and Rac1 and/or with Y27632 to block ROCK.